Medtronic confirms launch of diabetic-friendly Resolute Integrity stent in India

Fri, 09/28/2012 - 3:13pm
Mass Device

Medical device titan Medtronic's Resolute Integrity stent, the 1st with approval for use in patients with diabetes, makes its market debut in India, the country with the 2nd-largest population of diabetics.

Medtronic's Resolute Integrity stent

Medical device maker Medtronic (NYSE:MDT) confirmed market launch in India for its Resolute Integrity drug-eluting stent system for heart disease patients with diabetes.

The Resolute Integrity DES was the 1st device of its kind approved for use in patients with diabetes in addition to coronary artery disease, which makes up about ⅓ of all those with CAD.

With India hosting the 2nd largest population of diabetics in the world, the launch could be an important one for patients in the country as well as for Medtronic CEO Omar Ishrak's ongoing commitment to expanding the company's reach in emerging markets.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.